{"chunk_id": "medquad__chunk_41308", "source": "medquad", "text": "T activity that increase their risk of hematopoietic toxicity with thiopurine drug treatment.,GHR,thiopurine S-methyltransferase deficiency\nWhat are the genetic changes related to thiopurine S-methyltransferase deficiency ?,\"TPMT deficiency results from changes in the TPMT gene. This gene provides instructions for making the TPMT enzyme, which plays a critical role in breaking down (metabolizing) thiopurine drugs. Once inside the body, these drugs are converted to toxic compounds that kill immun"}